» Articles » PMID: 19770652

The Intestinal Microbiota in Health and Disease: the Influence of Microbial Products on Immune Cell Homeostasis

Overview
Specialty Gastroenterology
Date 2009 Sep 23
PMID 19770652
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose Of Review: A vast and diverse array of microbes colonizes the mammalian gastrointestinal tract. These microorganisms are integral in shaping the development and function of the immune system. Metagenomic sequencing analysis has revealed alterations in intestinal microbiota in patients suffering from chronic inflammatory diseases, including inflammatory bowel disease and asthma. This review will discuss the mechanisms through which the innate immune system recognizes and responds to the intestinal microbiota as well as the effect of specific microbiota-derived signals on immune cell homeostasis.

Recent Findings: Recent studies in murine model systems have demonstrated that manipulation of the intestinal microbiota can alter mammalian immune cell homeostasis. Specific microbial signals have been identified that can impact immune cell function both within the intestinal tract and in peripheral tissues. These microbiota-derived signals can either have an immunoregulatory effect, creating an immune state that is refractory to inflammation, or conversely, act as an adjuvant, aiding in the propagation of an immune response.

Summary: Associations between alterations in the microbiota and human disease implicate intestinal microbial signals in shaping immune responses. These signals are recognized by innate immune cells and influence the ability of these cells to modulate both the local and systemic immune response.

Citing Articles

Metabolic immaturity and breastmilk bile acid metabolites are central determinants of heightened newborn vulnerability to norovirus diarrhea.

Peiper A, Morales Aparicio J, Hu Z, Phophi L, Helm E, Rubinstein R Cell Host Microbe. 2024; 32(9):1488-1501.e5.

PMID: 39214086 PMC: 11392616. DOI: 10.1016/j.chom.2024.08.003.


Parkinson's disease and gut microbiota: from clinical to mechanistic and therapeutic studies.

Zhang X, Tang B, Guo J Transl Neurodegener. 2023; 12(1):59.

PMID: 38098067 PMC: 10722742. DOI: 10.1186/s40035-023-00392-8.


Effects of Glycyrrhiza Polysaccharides on Chickens' Intestinal Health and Homeostasis.

Wu Y, Wu C, Che Y, Zhang T, Dai C, Nguyn A Front Vet Sci. 2022; 9:891429.

PMID: 35647094 PMC: 9134109. DOI: 10.3389/fvets.2022.891429.


Mechanisms of immune regulation by the placenta: Role of type I interferon and interferon-stimulated genes signaling during pregnancy.

Ding J, Maxwell A, Adzibolosu N, Hu A, You Y, Liao A Immunol Rev. 2022; 308(1):9-24.

PMID: 35306673 PMC: 9189063. DOI: 10.1111/imr.13077.


How Does Epstein-Barr Virus Interact With Other Microbiomes in EBV-Driven Cancers?.

Wen Y, Xu H, Han J, Jin R, Chen H Front Cell Infect Microbiol. 2022; 12:852066.

PMID: 35281433 PMC: 8904896. DOI: 10.3389/fcimb.2022.852066.


References
1.
Sellon R, Tonkonogy S, Schultz M, Dieleman L, Grenther W, Balish E . Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun. 1998; 66(11):5224-31. PMC: 108652. DOI: 10.1128/IAI.66.11.5224-5231.1998. View

2.
Garrett W, Lord G, Punit S, Lugo-Villarino G, Mazmanian S, Ito S . Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell. 2007; 131(1):33-45. PMC: 2169385. DOI: 10.1016/j.cell.2007.08.017. View

3.
Casellas F, Borruel N, Papo M, Guarner F, Antolin M, Videla S . Antiinflammatory effects of enterically coated amoxicillin-clavulanic acid in active ulcerative colitis. Inflamm Bowel Dis. 1998; 4(1):1-5. DOI: 10.1097/00054725-199802000-00001. View

4.
Rimoldi M, Chieppa M, Salucci V, Avogadri F, Sonzogni A, Sampietro G . Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells. Nat Immunol. 2005; 6(5):507-14. DOI: 10.1038/ni1192. View

5.
Macpherson A, Khoo U, Forgacs I, Philpott-Howard J, Bjarnason I . Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Gut. 1996; 38(3):365-75. PMC: 1383064. DOI: 10.1136/gut.38.3.365. View